Viewing Study NCT01543451


Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2025-12-25 @ 9:48 PM
Study NCT ID: NCT01543451
Status: COMPLETED
Last Update Posted: 2014-03-26
First Post: 2012-02-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea
Sponsor: Helsinn Healthcare SA
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module